AZ’s Phil Krzyzek moves to Quintiles
April 12, 2010Sales and Marketing Quintiles, appointment, sales and marketing
Phil Krzyzek has joined Quintiles as UK business development director for its Commercial business. Phil was most recently a marketing …
Italy’s new R&D centre launched by Burns
April 9, 2010Research and Development Italy
The recently retired head of Roche’s pharma division has called for more public-private partnerships in the pharma industry. William Burns …
Merck to be hit by Cozaar generics
April 9, 2010Merck, Teva, generics
Generic versions of Merck’s hypertension treatments Cozaar and Hyzaar are to be launched in the US for the first time. …
Sanofi-Aventis signs drug with potential to reverse diabetes
April 9, 2010Research and Development Sanofi, diabetes
Sanofi-Aventis has signed a deal with a US biotech firm to develop a new treatment which could restore patients’ ability …
Mike Isles joins EAASM
April 9, 2010Manufacturing and Production EAASM, appointment, manufacturing and production, supply chain
The European Alliance for Access to Safe Medicines (EAASM) has appointed Mike Isles executive director. He was most recently at …
Genentech opens $400m fill-and-finish plant
April 8, 2010Manufacturing and Production Genentech
US biotech giant Genentech has officially opened its new 296,000 sq. ft. biologics manufacturing facility in Hillsboro, near Portland, Oregon. …
AstraZeneca dodges another Seroquel lawsuit
April 8, 2010Sales and Marketing AZ, Seroquel, US
AstraZeneca has defeated another US lawsuit seeking compensation for diabetes side-effects allegedly caused by its drug Seroquel. A US Federal …
Talking Point: Humour and healthcare advertising
April 8, 2010Medical Communications Pulsar, Talking Point, medical communications
It will come as no surprise when I say that humour in healthcare advertising is a rare occurrence. So why …
Edelman appoints Kajsa Wilhelmsson
April 8, 2010Medical Communications Edelman, appointment, medical communications
Kajsa Wilhelmsson has joined Edelman’s health practice as director of European health public affairs. She will be based in the …
ICON and Tigermed forge China alliance
April 7, 2010Research and Development CRO, China, ICON
Contract research organisation ICON is to team up with Tigermed Consulting, a clinical services company based in China. The alliance …
UK recoups cost from unused H1N1 vaccine
April 7, 2010Sales and Marketing GSK, NHS, h1n1
The UK government has agreed a deal with GlaxoSmithKine on surplus supplies of its H1N1 vaccine Pandemrix. The Department of …
Solvay reprimanded for cheques to GPs
April 7, 2010Sales and Marketing Code of Practice, PMCPA, Solvay
Three UK pharma companies have been ‘named and shamed’ for serious breaches of the ABPI’s Code of Practice. Solvay, Pfizer …
Sigma-Aldrich opens large-scale high-potency unit
April 7, 2010Manufacturing and Production Sigma-Aldrich
Sigma-Aldrich has increased its high-potency active pharmaceutical ingredient (HPAPI) production capacity with the opening of a newly-expanded facility that is …
GSK and Crucell to develop malaria vaccine
April 7, 2010Sales and Marketing Crucell, GSK, malaria
GlaxoSmithKline Biologicals and Dutch vaccines company Crucell are to develop a ‘second generation’ malaria vaccine candidate. Malaria causes 900,000 deaths …
Frank Pitzer made chief executive at NimbleGen
April 7, 2010Research and Development NimbleGen, Roche, appointment, research and development
Roche has promoted Dr Frank Pitzer to chief executive for its Madison, US headquartered genomics business NimbleGen. Dr Pitzer has …
New consultancy Strategic North launched
April 7, 2010Medical Communications, Sales and Marketing Consultancy, coleiro, marketing, marketing ideas, strategy
A new healthcare industry marketing consultancy based in the North West of England has been launched. Strategic North is a …
Publicis acquires In-Sync
April 6, 2010Medical Communications agency, medical communications, publicis
Global communications group Publicis has acquired Toronto-based In-Sync, a company specialising in healthcare market research. In-Sync will become part of …
Manufacturing news in brief
April 6, 2010Manufacturing and Production NIB, Valeant, Warner Chilcott, baxter
This week’s round-up of recent developments in the pharmaceutical manufacturing arena sees a new facility build for Ireland’s HKPB and …
Conservative claims on cancer drugs disputed
April 6, 2010Sales and Marketing NHS, NICE, election
A think tank has disputed Conservative claims that funds can be diverted to pay for greater access to new cancer …
Warner Chilcott gets Actonel lift
April 6, 2010Sales and Marketing Sanofi, Warner Chilcott, actonel, osteoporosis
Warner Chilcott has assumed all commercial responsibility for its osteoporosis drug Actonel in the US. Sanofi-Aventis has agreed to pass …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
